Mitsuhiro Ohta Selected Research

Mitsuhiro Ohta Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2010 - 12/2002
9	Insulin Resistance 01/2011 - 01/2004
8	Endometriosis 12/2007 - 01/2002
6	Parkinson Disease (Parkinson's Disease) 09/2006 - 07/2002
5	Obesity 04/2024 - 01/2004
5	Genetic Predisposition to Disease (Genetic Predisposition) 12/2007 - 01/2002
4	Myasthenia Gravis 06/2008 - 05/2003
3	Rheumatoid Arthritis 09/2014 - 03/2007
3	Infections 01/2013 - 10/2002
3	Neuroblastoma 09/2006 - 01/2003
2	Hypertension (High Blood Pressure) 11/2023 - 12/2006
2	Thrombosis (Thrombus) 11/2023 - 01/2019
2	Immune System Diseases (Immune Disorders) 09/2014 - 12/2007
2	Fibrosis (Cirrhosis) 03/2011 - 01/2011
2	Non-alcoholic Fatty Liver Disease 01/2011 - 04/2010
2	Hyperglycemia 01/2010 - 03/2009
2	Ischemia 10/2008 - 05/2005
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2007 - 08/2003
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 11/2002 - 11/2002
1	Overweight 04/2024
1	Neoplasms (Cancer) 11/2023
1	Inflammation (Inflammations) 11/2023
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Body Weight (Weight, Body) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 01/2013
1	Chronic Hepatitis C 01/2013
1	Breast Neoplasms (Breast Cancer) 11/2012
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2011
1	Fatty Liver 01/2011
1	Stomach Neoplasms (Stomach Cancer) 12/2009
1	Hypoxia (Hypoxemia) 10/2008
1	Glucose Intolerance 03/2008
1	Atopic Dermatitis (Atopic Eczema) 02/2007

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 09/2014 - 08/2004
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2004
4	Interleukin-6 (Interleukin 6)IBA 03/2011 - 08/2003
4	Biomarkers (Surrogate Marker)IBA 07/2008 - 11/2002
3	Insulin (Novolin)FDA Link 01/2019 - 07/2005
3	Lipoproteins (Lipoprotein)IBA 01/2011 - 04/2008
3	Cholinergic ReceptorsIBA 12/2007 - 05/2003
3	ImmunosorbentsIBA 01/2004 - 11/2002
3	EnzymesIBA 01/2004 - 11/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 01/2011
2	Ribavirin (Virazole)FDA LinkGeneric 01/2013 - 01/2011
2	InterferonsIBA 01/2013 - 01/2011
2	oxidized low density lipoproteinIBA 01/2011 - 01/2010
2	LipidsIBA 01/2011 - 03/2008
2	nasIBA 01/2011 - 04/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2008
2	AdiponectinIBA 01/2010 - 12/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009 - 02/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 02/2007
2	muskIBA 06/2008 - 09/2007
2	AutoantibodiesIBA 06/2008 - 09/2007
2	Retinaldehyde (Retinal)IBA 09/2007 - 08/2003
2	pentosidineIBA 09/2007 - 08/2003
2	Advanced Glycation End ProductsIBA 09/2007 - 08/2003
2	Oxidopamine (6 Hydroxydopamine)IBA 09/2006 - 11/2003
2	Apomorphine FDA Link 09/2006 - 01/2003
2	Dopamine (Intropin)FDA LinkGeneric 09/2006 - 11/2003
2	ResistinIBA 01/2006 - 01/2004
2	AntibodiesIBA 07/2005 - 01/2004
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2004 - 02/2003
2	Myelin Basic ProteinIBA 11/2002 - 11/2002
1	xanthoangelolIBA 04/2024
1	Chalcone (Benzalacetophenone)IBA 04/2024
1	ChalconesIBA 11/2023
1	sebacic acidIBA 05/2022
1	10-hydroxydecanoic acidIBA 05/2022
1	10-hydroxy-2-decenoic acidIBA 05/2022
1	royal jellyIBA 05/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 09/2014
1	CholesterolIBA 01/2011
1	N 30IBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Ezetimibe (Zetia)FDA Link 01/2011
1	Collagen Type IV (Type IV Collagen)IBA 04/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 01/2010
1	Pioglitazone (Actos)FDA Link 01/2010
1	Telmisartan (Micardis)FDA Link 03/2009
1	Superoxides (Superoxide)IBA 10/2008
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 10/2008
1	Glycoside Hydrolase InhibitorsIBA 04/2008
1	glimepiride (Amarel)FDA LinkGeneric 04/2008
1	Acarbose FDA LinkGeneric 04/2008
1	HydrogenIBA 03/2008
1	Alkaline PhosphataseIBA 12/2007
1	KIR ReceptorsIBA 12/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	Angiotensin Receptor AntagonistsIBA 09/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2007

Therapy/Procedure

5	Therapeutics 01/2013 - 09/2006
1	Aftercare (After-Treatment) 01/2011